LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
Copyright: © 2020, Yeboah et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License. Despite advances in identifying the key immunoregulatory roles of many of the human leukocyte immunoglobulin-like receptor (LILR) family members, t...
Main Authors: | Yeboah, Muchaala, Papagregoriou, Charys, Jones, Des C, Chan, HT Claude, Hu, Guangan, McPartlan, Justine S, Schiött, Torbjörn, Mattson, Ulrika, Mockridge, C Ian, Tornberg, Ulla-Carin, Hambe, Björn, Ljungars, Anne, Mattsson, Mikael, Tews, Ivo, Glennie, Martin J, Thirdborough, Stephen M, Trowsdale, John, Frendeus, Björn, Chen, Jianzhu, Cragg, Mark S, Roghanian, Ali |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2021
|
Online Access: | https://hdl.handle.net/1721.1/134054 |
Similar Items
-
The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells.
by: Young, N, et al.
Published: (2008) -
Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j).
by: Shiroishi, M, et al.
Published: (2006) -
The ILT family of leukocyte receptors.
by: Allan, D, et al.
Published: (2000) -
Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.
by: Lepin, E, et al.
Published: (2000) -
Structural basis for RIFIN-mediated activation of LILRB1 in malaria
by: Harrison, TE, et al.
Published: (2020)